Peptides from Pseudomonas syringae possessing broad-spectrum antibiotic activity
US5837685A · kind A · utility
8Cited by
1References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 27, 1996 |
| Grant date | Nov 17, 1998 |
| Priority date | — |
| Expiry date | Jun 27, 2016 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/874
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Peptide antimycotics, termed pseudomycins, display broad spectrum antibiotic activity, and in particular are highly effective, non-toxic antibiotics against fungal pathogens of human and animal disease. The peptide antimycotics (pseudomycins) may be used in the treatment of the fungal pathogen Candida albicans. Also disclosed is a method of purification and isolation, including characterization, of the pseudomycins.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.